Skip to main content
Erschienen in:

01.03.2023 | Research

Adherence, safety, and satisfaction of a cardio-oncology rehabilitation program framework versus community exercise training for cancer survivors: findings from the CORE trial

verfasst von: Sofia Gonçalves Viamonte, Ana Joaquim, Alberto Alves, Eduardo Vilela, Andreia Capela, Cristina Ferreira, Ana João Costa, Madalena Teixeira, Barbara Duarte, Nuno Rato, Aida Tavares, Mário Santos, Fernando Ribeiro

Erschienen in: Supportive Care in Cancer | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To assess safety, satisfaction, and overall adherence of a center-based cardiac rehabilitation (CBCR) program for cancer survivors at increased cardiovascular (CV) risk, compared to community-based exercise training (CBET).

Methods

The CORE study was a single-center, prospective, randomized controlled trial enrolling cancer survivors exposed to cardiotoxic cancer treatment and/or with previous CV disease. Participants were randomized to an 8-week CBCR program or CBET, twice a week. Overall feasibility (consent, retention, and completion rates), intervention adherence (percentage of exercise sessions attended), and safety were assessed. Adverse events (AEs) were registered, and participants’ satisfaction was measured at the end of the study.

Results

Eighty out of 116 potentially eligible individuals were included; consent rate was 72.4%, and 77 (96.2%) started the study (retention rate 100% in CBCR vs 92.5% in CBET); completion rate was 92.5%. Intervention adherence was higher in CBCR (90.3 ± 11.8% vs 68.4 ± 22.1%, p < 0.001). Exercise-related AEs were mainly related to musculoskeletal conditions in both groups (7 in CBCR vs 20 in CBET, p < 0.001), accounting for exercise prescription modification in 47 sessions (18 (3.3%) in CBCR vs 29 (7.2%) in CBET, p = 0.006), none motivating exercise discontinuation. No participants reported major CV events. Overall, the satisfaction with the different aspects of the programs (e.g., expectations, monitoring) was higher in the CBCR.

Conclusion

This exploratory analysis of the CORE trial suggests that both exercise-based interventions are feasible and safe in this setting. The higher intervention adherence and patient satisfaction in CBCR suggest that this comprehensive approach could be of interest in this population.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Lyon AR, López-Fernández T, Couch LS, et al. (2022) ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) [published online ahead of print, 2022 Aug 26]. Eur Heart J ehac244. https://doi.org/10.1093/eurheartj/ehac244 Lyon AR, López-Fernández T, Couch LS, et al. (2022) ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) [published online ahead of print, 2022 Aug 26]. Eur Heart J ehac244. https://​doi.​org/​10.​1093/​eurheartj/​ehac244
4.
Zurück zum Zitat Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M et al (2016) 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J 37(36):2768–2801. https://doi.org/10.1093/eurheartj/ehw211CrossRefPubMed Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M et al (2016) 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J 37(36):2768–2801. https://​doi.​org/​10.​1093/​eurheartj/​ehw211CrossRefPubMed
14.
Zurück zum Zitat Murray J, Bennett H, Bezak E, Perry R (2021) The role of exercise in the prevention of cancer therapy-related cardiac dysfunction in breast cancer patients undergoing chemotherapy: systematic review [published online ahead of print, 2021 Mar 9]. Eur J Prev Cardiol. https://doi.org/10.1093/eurjpc/zwab006 Murray J, Bennett H, Bezak E, Perry R (2021) The role of exercise in the prevention of cancer therapy-related cardiac dysfunction in breast cancer patients undergoing chemotherapy: systematic review [published online ahead of print, 2021 Mar 9]. Eur J Prev Cardiol. https://​doi.​org/​10.​1093/​eurjpc/​zwab006
17.
Zurück zum Zitat D'Ascenzi F, Anselmi F, Fiorentini C, Mannucci R, Bonifazi M, Mondillo S (2019) The benefits of exercise in cancer patients and the criteria for exercise prescription in cardio-oncology [published online ahead of print, 2019 Oct 16]. Eur J Prev Cardiol. https://doi.org/10.1177/2047487319874900 D'Ascenzi F, Anselmi F, Fiorentini C, Mannucci R, Bonifazi M, Mondillo S (2019) The benefits of exercise in cancer patients and the criteria for exercise prescription in cardio-oncology [published online ahead of print, 2019 Oct 16]. Eur J Prev Cardiol. https://​doi.​org/​10.​1177/​2047487319874900​
18.
19.
Zurück zum Zitat Díaz-Balboa E, González-Salvado V, Rodríguez-Romero B, Martínez-Monzonís A, Pedreira-Pérez M, Palacios-Ozores P et al (2021) A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol. BMC Cardiovasc Disord 21(1):165. https://doi.org/10.1186/s12872-021-01970-2CrossRefPubMedPubMedCentral Díaz-Balboa E, González-Salvado V, Rodríguez-Romero B, Martínez-Monzonís A, Pedreira-Pérez M, Palacios-Ozores P et al (2021) A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol. BMC Cardiovasc Disord 21(1):165. https://​doi.​org/​10.​1186/​s12872-021-01970-2CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Hubbard G, O’Carroll R, Munro J et al (2016) The feasibility and acceptability of trial procedures for a pragmatic randomised controlled trial of a structured physical activity intervention for people diagnosed with colorectal cancer: findings from a pilot trial of cardiac rehabilitation versus usual care (no rehabilitation) with an embedded qualitative study. Pilot Feasibility Stud 2:51. https://doi.org/10.1186/s40814-016-0090-yCrossRefPubMedPubMedCentral Hubbard G, O’Carroll R, Munro J et al (2016) The feasibility and acceptability of trial procedures for a pragmatic randomised controlled trial of a structured physical activity intervention for people diagnosed with colorectal cancer: findings from a pilot trial of cardiac rehabilitation versus usual care (no rehabilitation) with an embedded qualitative study. Pilot Feasibility Stud 2:51. https://​doi.​org/​10.​1186/​s40814-016-0090-yCrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Abreu A, Frederix I, Dendale P, Janssen A, Doherty P, Piepoli MF et al (2020) Standardization and quality improvement of secondary prevention through cardiovascular rehabilitation programmes in Europe: the avenue towards EAPC accreditation programme: a position statement of the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol. https://doi.org/10.1177/2047487320924912CrossRefPubMedPubMedCentral Abreu A, Frederix I, Dendale P, Janssen A, Doherty P, Piepoli MF et al (2020) Standardization and quality improvement of secondary prevention through cardiovascular rehabilitation programmes in Europe: the avenue towards EAPC accreditation programme: a position statement of the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol. https://​doi.​org/​10.​1177/​2047487320924912​CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Viamonte SG, Joaquim A, Alves A, Vilela E, Capela A, Ferreira C, et al. Impact of a comprehensive cardiac rehabilitation framework among high cardiovascular risk cancer survivors: rationale and study design of the CORE trial. Int J Cardiol, (published ahead of print). https://doi.org/10.1016/j.ijcard.2022.09.075 Viamonte SG, Joaquim A, Alves A, Vilela E, Capela A, Ferreira C, et al. Impact of a comprehensive cardiac rehabilitation framework among high cardiovascular risk cancer survivors: rationale and study design of the CORE trial. Int J Cardiol, (published ahead of print). https://​doi.​org/​10.​1016/​j.​ijcard.​2022.​09.​075
27.
Zurück zum Zitat Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL et al (2016) 2016 European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 37(29):2315–2381. https://doi.org/10.1093/eurheartj/ehw106CrossRefPubMedPubMedCentral Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL et al (2016) 2016 European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 37(29):2315–2381. https://​doi.​org/​10.​1093/​eurheartj/​ehw106CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) (2020) Guidelines for cardiac rehabilitation and secondary prevention programs. 6th Edition. Human Kinetics 4 American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) (2020) Guidelines for cardiac rehabilitation and secondary prevention programs. 6th Edition. Human Kinetics 4
30.
Zurück zum Zitat Common Terminology Criteria for Adverse Events (CTCAE) version 5. Published: November 27, 2017. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) version 5. Published: November 27, 2017. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute
34.
Zurück zum Zitat Lopes S, Felix G, Bastos J, Figueiredo D, Oliveira J, Ribeiro F. Determinants of exercise adherence and maintenance among patients with hypertension: a narrative review. Rev Cardiovasc Med. 2021 Dec 22;22(4):1271–1278. https://doi.org/10.31083/j.rcm2204134. Lopes S, Felix G, Bastos J, Figueiredo D, Oliveira J, Ribeiro F. Determinants of exercise adherence and maintenance among patients with hypertension: a narrative review. Rev Cardiovasc Med. 2021 Dec 22;22(4):1271–1278. https://​doi.​org/​10.​31083/​j.​rcm2204134.
Metadaten
Titel
Adherence, safety, and satisfaction of a cardio-oncology rehabilitation program framework versus community exercise training for cancer survivors: findings from the CORE trial
verfasst von
Sofia Gonçalves Viamonte
Ana Joaquim
Alberto Alves
Eduardo Vilela
Andreia Capela
Cristina Ferreira
Ana João Costa
Madalena Teixeira
Barbara Duarte
Nuno Rato
Aida Tavares
Mário Santos
Fernando Ribeiro
Publikationsdatum
01.03.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 3/2023
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-023-07638-1

Neu im Fachgebiet Onkologie

ctDNA erkennt minimale Resterkrankung beim Melanom

Die Diagnose einer minimalen Resterkrankung mithilfe zirkulierender Tumor-DNA könnte (ctDNA) auch das Management von Patientinnen und Patienten mit Melanomen im Stadium III bereichern, wie Ergebnisse einer Studie nahelegen – auch wenn die Methode noch nicht perfekt funktioniert.

Höhere Dosis von Dexamethason senkt Überlebenschancen

Personen mit Hirnmetastasen, die perioperativ höhere kumulative Dosen von Dexamethason erhalten, haben eine schlechtere Prognose. Um die Ergebnisse zu verbessern, bedarf es strengerer Dosierungsschemata.

Ringen um den richtigen Umgang mit Zufallsbefunden

Wenn 2026 in Deutschland das Lungenkrebsscreening mittels Low-Dose-Computertomografie (LDCT) eingeführt wird, wird es auch viele Zufallsbefunde ans Licht bringen. Das birgt Chancen und Risiken.

Bald 5% der Krebserkrankungen durch CT verursacht

Die jährlich rund 93 Millionen CTs in den USA könnten künftig zu über 100.000 zusätzlichen Krebserkrankungen führen, geht aus einer Modellrechnung hervor. Damit würde eine von 20 Krebserkrankungen auf die ionisierende Strahlung bei CT-Untersuchungen zurückgehen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.